Versigent (VGNT) CEO awarded 111,698 Ordinary Shares in equity grant

Rhea-AI Filing Summary

Liotine Joseph T. reported acquisition or exercise transactions in this Form 4 filing.

Versigent PLC disclosed that CEO and director Joseph T. Liotine received a grant of 111,698 Ordinary Shares on April 22, 2026. The award was recorded at a price of $0.00 per share, indicating it is a compensation-related equity grant rather than an open-market purchase. Following this grant, Liotine directly holds 230,153 Ordinary Shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Liotine Joseph T.

Role CEO and Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	111,698	$0.00	--

Holdings After Transaction: Ordinary Shares — 230,153 shares (Direct, null)

Footnotes (1)

Key Figures

Shares granted: 111,698 shares Grant price: $0.00 per share Shares held after: 230,153 shares

3 metrics

Shares granted 111,698 shares Ordinary Share grant to CEO on April 22, 2026

Grant price $0.00 per share Recorded transaction price for equity award

Shares held after 230,153 shares CEO direct ownership following the grant

Key Terms

Ordinary Shares, Grant, award, or other acquisition, non-derivative, Form 4

4 terms

Ordinary Shares financial

"security_title: "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

non-derivative financial

"transaction_type: "non-derivative""

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Liotine Joseph T.

(Last) (First) (Middle)

SPITALSTRASSE 5,

(Street)

SCHAFFHAUSEN SWITZERLAND 8200

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Versigent PLC [ VGNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and Director

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	04/22/2026		A		111,698	A	$0.00	230,153	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Janis Acosta, Attorney-in-fact for Joseph T. Liotine	04/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Versigent (VGNT) report for Joseph T. Liotine?

Versigent reported that CEO and director Joseph T. Liotine received a grant of 111,698 Ordinary Shares as equity compensation. The grant was recorded at $0.00 per share and increased his direct holdings to 230,153 Ordinary Shares after the transaction.

Was the Versigent (VGNT) CEO’s Form 4 transaction a stock purchase or a grant?

The Form 4 shows a grant or award, not an open-market purchase. Joseph T. Liotine acquired 111,698 Ordinary Shares under transaction code A, which indicates a compensation-related grant, recorded at $0.00 per share rather than a market-priced buy.

How many Versigent (VGNT) shares does CEO Joseph T. Liotine own after this grant?

After the reported grant, Joseph T. Liotine directly holds 230,153 Ordinary Shares of Versigent. This figure reflects his position immediately following the award of 111,698 shares disclosed in the Form 4, and represents his direct ownership only.

What does transaction code A mean in the Versigent (VGNT) Form 4 filing?

Transaction code A in the Form 4 indicates a grant, award, or other acquisition of securities. For Versigent, it shows CEO Joseph T. Liotine received 111,698 Ordinary Shares as an equity grant, rather than purchasing those shares in the open market.

Did the Versigent (VGNT) CEO pay anything for the 111,698 granted shares?

The filing reports a transaction price of $0.00 per share for the 111,698 Ordinary Shares. This indicates the shares were granted as part of compensation or an award program, with no cash price paid in the transaction itself.